Skip to content

Effects of propofol and propofol on postoperative short-term renal function in patients undergoing nephrectomy

Effects of propofol and propofol on postoperative short-term renal function in patients undergoing nephrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097732
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-02-26
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney disease

Interventions

Propofol group:General anesthesia was induced with propofol ( 2mg / kg ) and maintained with propofol ( initial maintenance dose of 5mg / kg / h ) combined with opioids ( remifentanil ) and cis-atracu
Cyclopophenol group:General anesthesia was induced with propofol ( 0.4 mg / kg ), and maintained with propofol ( initial maintenance dose of 0.8 mg / kg / h ) combined with opioids ( remifentanil ) an

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Age 35-80 years old ; ( 2 ) Deviation from ideal weight <= 25 % ; ( 3 ) American Society of Anesthesiologists ASA I-III ; ( 4 ) Patients with partial nephrectomy or pyeloplasty ; ( 5 ) There was no history of long-term use of analgesic, sedative and anti-anxiety drugs ; ( 6 ) Informed consent, volunteered to participate in the trial, and signed informed consent.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients refused ; ( 2 ) weight more than the ideal weight +/- 25 % ; ( 3 ) pregnancy or breastfeeding ; ( 4 ) Patients with communication disorders, cognitive dysfunction, and a history of mental illness ; ( 5 ) Allergic to propofol or propofol ; ( 6 ) patients with hereditary malignant high fever and severe renal insufficiency ; ( 7 ) Subjects who were considered unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Serum creatinine on the first day after surgery;Creatinine clearance rate on the first postoperative day;Urine volume one hour after operation;

Secondary

MeasureTime frame
Postoperative quality of life score;The decrease of mean arterial pressure during anesthesia induction;Vital sign;Use of vasoactive drugs;Incidence of adverse events;

Countries

China

Contacts

Public ContactGuanghong Xu

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 138 5694 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026